Importance of the Renin-Angiotensin-Aldosterone System (RAS) in the Physiology and Pathology of Hypertension: An Overview

Drugs

Volumn 39, Issue 2, 1990, Pages 1-8

  Ferrario, Carlos M ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN II DERIVATIVE;

BRAIN; CONFERENCE PAPER; ESSENTIAL HYPERTENSION; HEART; HUMAN; KIDNEY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SMOOTH MUSCLE;

ANGIOTENSIN II; ANIMAL; BRAIN; HUMAN; HYPERTENSION; RENIN-ANGIOTENSIN SYSTEM;

EID: 0025325227     PISSN: 00126667     EISSN: 11791950     Source Type: Journal    
DOI: 10.2165/00003495-199000392-00002     Document Type: Article

References (48)

1. The ventrolateral medulla: a new site of the action of the renin-angio-tensin system
2. Approaches to establishing angiotensin II as a neurotransmitter
3. Long term treatment of hypertension in man by an orally active angiotensin-converting enzyme inhibitor
4. What we would like to know about the antihypertensive mechanisms of angiotensin converting enzyme inhibition
5. Angiotensin converting enzyme in rat brain visualized by quantitative in vitro autoradiography
6. Baroreflex function in lifetime-captopril-treated spontaneously hypertensive rats
7. The CONSENSUS Trial Study Group
8. Restriction fragment length polymorphisms for the renin gene in Dahl rats
9. Co-localization of angiotensinogen and glial fibrillary acidic protein in astrocytes in rat brain
10. Evidence for the presence of angiotensins in normal, unstimulated alveolar macrophages and monocytes
11. Functional characteristics of neuropeptides in the dorsal medulla oblongata and vagus nerve
12. Autocrine-paracrine mechanisms of vascular myocytes in hypertension
13. Captopril potentiates chronotropic baroreflex responses to carotid stimuli in humans
14. Epidemiology of renin
15. Interactions between coronary occlusion and the renin-angiotensin system in the dog
16. Neurogenic actions of angiotensin II
17. Role of area postrema pressor mechanisms in the regulation of arterial pressure
18. A hypothesis regarding the function of angiotensin peptides in the brain
19. Angiotensin converting enzyme inhibitors. Present and future
20. Angiotensin-sensitive neurons in the rat paraventricular nucleus: relative potencies of angiotensin II and angiotensin III
21. Captopril: a preliminary review of its pharmacological properties and therapeutic efficacy
22. A market analyst’s perspective on hypertension and its treatment
23. Baroreflex sensitivity during converting enzyme inhibition with enalapril (MK-421) in normal man
24. Structure and function of renin
25. Inhibition of angiotensin converting enzyme (ACE) in plasma and tissues: studies ex vivo after administration of ACE inhibitors
26. Conceptual diagnostic and therapeutic dimensions of renin-system profiling of hypertensive disorders and of congestive heart failure. Four new research frontiers
27. The distribution of angiotensin II-immunoreactive cells and fibers in the paraventriculo-hypophysial system of the rat
28. Organization of angiotensin II immunoreactive cells and fibers in the rat central nervous system
29. Tissue renin-angiotensin systems: focus on the heart
30. Reflex control of circulation and angiotensin converting enzyme inhibition in man
31. Modification of arterial baroreflexes by captoprii in essential hypertension
32. Effects of central and peripheral angiotensin blockade in hypertensive rats
33. 125I-labelled MK351A
34. Structure of the human renin gene
35. Cloning and sequence analysis of cDNA for rat angiotensinogen
36. The place of renin in the mechanism of hypertension in chronic renal disease
37. Studies of the cellular biology of the myocardium: cellular mechanisms of growth in cardiovascular tissue
38. Angiotensin II binding sites in the conduction system of rat hearts
39. A major structural abnormality in the renin gene of the spontaneously hypertensive rat
40. Converting enzyme activity and angiotensin metabolism in the dog brain stem
41. Release of vasopressin from the rat hypothalamo-neurophypophysial system by Ang-(l–7) heptapeptide
42. Angiotensin I and II forming enzymes in the central nervous system
43. Alterations in plasma and cerebrospinal fluid norepinephrine and angiotensin II during the development of renal hypertension in conscious dogs
44. Changes in central and peripheral renin-angiotensin system after furosemide injection
45. Enalapril: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in hypertension and congestive heart failure